- California Assembly OKs highest minimum wage in nation
- S. Korea unveils first graphic cigarette warnings
- US joins with South Korea, Japan in bid to deter North Korea
- LPGA golfer Chun In-gee finally back in action
- S. Korea won’t be top seed in final World Cup qualification round
- US men’s soccer misses 2nd straight Olympics
- US back on track in qualifying with 4-0 win over Guatemala
- High-intensity workout injuries spawn cottage industry
- CDC expands range of Zika mosquitoes into parts of Northeast
- Who knew? ‘The Walking Dead’ is helping families connect
Prosecution needs to stop probe into Samsung chief’s alleged propofol use: expert panel
A panel of civilian experts decided Friday to recommend that the state prosecution service halt its investigation into the allegation that Lee Jae-yong, the jailed de facto leader of Samsung Group, had taken propofol shots illegally.
The committee of outside experts plans to deliver the opinion, which is not binding, to the Supreme Prosecutors Office.
Among the 14 members of the panel who took part in the voting, eight opposed the continuation of the probe, and the rest favored it.
They failed to make a decision on whether Lee should be indicted over the suspicion, as they were evenly split over it.
Lee Jae-yong, vice chairman of Samsung Electronics Co., in a file photo (Yonhap)
A prosecution team in charge of the case said it would carry out a “comprehensive” review of the results of its investigation so far and the panel’s decision.
Lee is suspected of having excessively and illegally taken the anesthesia drug at a plastic surgery clinic in Seoul in 2017-2018.
He has denied the allegation, arguing that he used propofol “normally” in accordance with a doctor’s prescription.
He requested the case be reviewed by the independent panel to see whether the prosecution’s investigation is necessary.
The prosecution service introduced the outside review system in 2018 in a bid to enhance neutrality and fairness in handling cases that are of great public interest.